Latest posts in
Reports
Capital Rx
April 17, 2023
/
Capital Rx's Q1 '23 pipeline report, developed by our clinical pharmacists, highlights the latest drug approvals and pipeline updates.
Capital Rx
January 20, 2023
/
Capital Rx's clinical pharmacists' quarterly summary of the latest drug approvals and pipeline developments.
Capital Rx
October 25, 2022
/
The Q3-2022 Capital Rx Pipeline Report is now available; our Clinical Pharmacists designed this to keep you up to date on the latest drug approvals/FDA drug pipeline.
August 8, 2022
/
The Q2-2022 Capital Rx Pipeline Report is developed by our Clinical Pharmacists and published quarterly. It is designed to keep you up to date on the latest drug approvals and well-versed on what is to come in the FDA drug pipeline.
May 3, 2022
/
The 2022 Q1 Capital Rx Pipeline Report is developed by our Clinical Pharmacists and published quarterly. It is designed to keep you up to date on the latest drug approvals and well-versed on what is to come in the FDA drug pipeline.
March 10, 2022
/
The 2021 Q3 & Q4 Capital Rx Pipeline Report is developed by our Clinical Pharmacists and published quarterly. It is designed to keep you up to date on the latest drug approvals and well-versed on what is to come in the FDA drug pipeline.
